These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10529983)

  • 1. The phacomatoses.
    Kerrison JB; Newman NJ
    Neurosurg Clin N Am; 1999 Oct; 10(4):775-87, x. PubMed ID: 10529983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-ophthalmology of the phacomatoses.
    Kerrison JB
    Curr Opin Ophthalmol; 2000 Dec; 11(6):413-20. PubMed ID: 11141635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-cranial manifestations of the neurocutaneous syndromes.
    Herron J; Darrah R; Quaghebeur G
    Clin Radiol; 2000 Feb; 55(2):82-98. PubMed ID: 10657153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocutaneous syndromes.
    Dahan D; Fenichel GM; El-Said R
    Adolesc Med; 2002 Oct; 13(3):495-509. PubMed ID: 12270797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cancer syndromes of the skin.
    Somoano B; Niendorf KB; Tsao H
    Clin Dermatol; 2005; 23(1):85-106. PubMed ID: 15708293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of familial melanoma and nonmelanoma skin cancer syndromes.
    Santillan AA; Cherpelis BS; Glass LF; Sondak VK
    Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalocraniocutaneous lipomatosis: clinical spectrum of systemic involvement.
    Sofiatti A; Cirto AG; Arnone M; Romiti R; Santi C; Leite C; Sotto M
    Pediatr Dermatol; 2006; 23(1):27-30. PubMed ID: 16445407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phacomatosis].
    Valeyrie-Allanore L; Wolkenstein P
    Rev Prat; 2008 Apr; 58(7):717-24. PubMed ID: 18546640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographical Profile and Spectrum of Multiple Malignancies in Children and Adults with Neurocutaneous Disorders.
    Marjanska A; Jatczak-Gaca A; Wojtkiewicz A; Wysocki M; Styczynski J
    Anticancer Res; 2018 Sep; 38(9):5453-5457. PubMed ID: 30194202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin symptoms in neurological diseases].
    Burg G; Burg D
    Ther Umsch; 1995 Apr; 52(4):243-50. PubMed ID: 7754467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eye and phacomatoses.
    Joshi L; Taylor SR; Lightman S
    Br J Hosp Med (Lond); 2011 Dec; 72(12):677-81. PubMed ID: 22241224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phacomatosis and genetically determined tumors: the transition from childhood to adulthood].
    de Ribaupierre S; Vernet O; Vinchon M; Rilliet B
    Neurochirurgie; 2008 Oct; 54(5):642-53. PubMed ID: 18752812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocutaneous melanosis.
    Makkar HS; Frieden IJ
    Semin Cutan Med Surg; 2004 Jun; 23(2):138-44. PubMed ID: 15295923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmologic manifestations of cutaneous conditions.
    Freiman A; Ting PT; Barankin B; Stanciu M; Rudnisky C
    Ophthalmologica; 2006; 220(5):281-4. PubMed ID: 16954702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic infantile neurological, cutaneous, and articular syndrome with severe early articular manifestations.
    Leys C; Eschard C; Motte J; Prieur AM; Kalis B; Bernard P
    Pediatr Dermatol; 2005; 22(3):222-6. PubMed ID: 15916569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous lesions in genetic tumor syndromes].
    Christen-Zaech S; Vernez M
    Rev Med Suisse; 2008 Apr; 4(155):1095-102. PubMed ID: 18610722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phacomatoses].
    Reith W
    Radiologe; 2013 Dec; 53(12):1075-6. PubMed ID: 24292368
    [No Abstract]   [Full Text] [Related]  

  • 18. The many faces of PHACE syndrome.
    Metry DW; Dowd CF; Barkovich AJ; Frieden IJ
    J Pediatr; 2001 Jul; 139(1):117-23. PubMed ID: 11445804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the identification of hereditary cancer for routine oncological diagnosis].
    Weissflog G; Wand D; Schwarz R
    Dtsch Med Wochenschr; 2006 Jan; 131(1-2):26-8. PubMed ID: 16374739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.